Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Clostridium difficile is not associated with outbreaks of viral gastroenteritis in the elderly in the Netherlands.

Svraka S, Kuijper E, Duizer E, Bakker D, Koopmans M.

Eur J Clin Microbiol Infect Dis. 2010 Jun;29(6):677-82. doi: 10.1007/s10096-010-0913-3. Epub 2010 Mar 27.

2.

[Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].

Deniz U, Ulger N, Aksu B, Karavuş M, Söyletir G.

Mikrobiyol Bul. 2011 Jan;45(1):1-10. Turkish.

PMID:
21341153
3.

Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.

Goldenberg SD, Cliff PR, Smith S, Milner M, French GL.

J Hosp Infect. 2010 Jan;74(1):48-54. doi: 10.1016/j.jhin.2009.08.014. Epub 2009 Nov 8.

PMID:
19900734
4.

Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands.

Bauer MP, Veenendaal D, Verhoef L, Bloembergen P, van Dissel JT, Kuijper EJ.

Clin Microbiol Infect. 2009 Dec;15(12):1087-92. doi: 10.1111/j.1469-0691.2009.02853.x. Epub 2009 Jul 16.

5.

Evaluation of different methods for detection of Clostridium difficile toxins in Poland.

Martirosian G, Pituch H, Obuch-Woszczatyński P, Rouyan G, Meisel-Mikołajczyk F.

Acta Microbiol Pol. 1999;48(4):349-53.

PMID:
10756719
6.

Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea.

Morelli MS, Rouster SD, Giannella RA, Sherman KE.

Clin Gastroenterol Hepatol. 2004 Aug;2(8):669-74.

PMID:
15290659
7.

Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens.

Vanpoucke H, De Baere T, Claeys G, Vaneechoutte M, Verschraegen G.

Clin Microbiol Infect. 2001 Feb;7(2):55-64.

8.

Diagnosing toxigenic Clostridium difficile: new confidence bounds show culturing increases sensitivity of the toxin A/B enzyme immunoassay and refute gold standards.

Mattner F, Winterfeld I, Mattner L.

Scand J Infect Dis. 2012 Aug;44(8):578-85. doi: 10.3109/00365548.2012.655772. Epub 2012 Mar 11.

PMID:
22404319
9.

What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains.

Dumford DM 3rd, Nerandzic MM, Eckstein BC, Donskey CJ.

Am J Infect Control. 2009 Feb;37(1):15-9. doi: 10.1016/j.ajic.2008.07.009.

PMID:
19171247
10.

The diagnosis of Clostridium difficile-associated diarrhea: comparison of Triage C. difficile panel, EIA for Tox A/B and cytotoxin assays.

Alfa MJ, Swan B, VanDekerkhove B, Pang P, Harding GK.

Diagn Microbiol Infect Dis. 2002 Aug;43(4):257-63.

PMID:
12151184
11.

Clostridium difficile ribotype 027, toxinotype III, the Netherlands.

Kuijper EJ, van den Berg RJ, Debast S, Visser CE, Veenendaal D, Troelstra A, van der Kooi T, van den Hof S, Notermans DW.

Emerg Infect Dis. 2006 May;12(5):827-30.

12.

Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France.

Barbut F, Lalande V, Burghoffer B, Thien HV, Grimprel E, Petit JC.

J Clin Microbiol. 2002 Jun;40(6):2079-83.

13.

Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands.

Hensgens MP, Goorhuis A, Notermans DW, van Benthem BH, Kuijper EJ.

Euro Surveill. 2009 Nov 12;14(45). pii: 19402.

14.

Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands.

Goorhuis A, Van der Kooi T, Vaessen N, Dekker FW, Van den Berg R, Harmanus C, van den Hof S, Notermans DW, Kuijper EJ.

Clin Infect Dis. 2007 Sep 15;45(6):695-703. Epub 2007 Aug 6.

PMID:
17712752
15.

Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection.

Nemat H, Khan R, Ashraf MS, Matta M, Ahmed S, Edwards BT, Hussain R, Lesser M, Pekmezaris R, Dlugacz Y, Wolf-Klein G.

Am J Gastroenterol. 2009 Aug;104(8):2035-41. doi: 10.1038/ajg.2009.174. Epub 2009 Apr 14.

PMID:
19367273
17.
18.

High prevalence of Clostridium difficile colonization among nursing home residents in Hesse, Germany.

Arvand M, Moser V, Schwehn C, Bettge-Weller G, Hensgens MP, Kuijper EJ.

PLoS One. 2012;7(1):e30183. doi: 10.1371/journal.pone.0030183. Epub 2012 Jan 11.

19.

Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany.

Borgmann S, Kist M, Jakobiak T, Reil M, Scholz E, von Eichel-Streiber C, Gruber H, Brazier JS, Schulte B.

Euro Surveill. 2008 Dec 4;13(49). pii: 19057.

20.

[Clostridium difficile ribotype 027, toxinotype III in The Netherlands].

Kuijper EJ, Debast SB, Van Kregten E, Vaessen N, Notermans DW, van den Broek PJ.

Ned Tijdschr Geneeskd. 2005 Sep 17;149(38):2087-9. Dutch.

PMID:
16201596

Supplemental Content

Support Center